FDA Inspection 1254788 — Stridelink Inc

Stridelink Inc — FEI 3029303083

The FDA completed an inspection of Stridelink Inc on Nov 20, 2024 in Atlanta, GA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Nov 20, 2024
Fiscal Year
2025
Product Type
Devices
Project Area
Compliance: Devices
Location
Atlanta, GA (United States)

Citations

IDCFRDescription
312721 CFR 820.80(e)Documentation
320721 CFR 820.50(b)Supplier notification of changes

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.